157 related articles for article (PubMed ID: 22310593)
1. Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients.
Tsuchiya T; Ishida K; Ito S; Deguchi T
Transplant Proc; 2012 Jan; 44(1):118-20. PubMed ID: 22310593
[TBL] [Abstract][Full Text] [Related]
2. Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.
Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
Transplant Proc; 2012 Jan; 44(1):128-33. PubMed ID: 22310596
[TBL] [Abstract][Full Text] [Related]
3. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
4. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
Ruangkanchanasetr P; Sanohdontree N; Supaporn T; Sathavarodom N; Satirapoj B
Ann Transplant; 2016 Dec; 21():765-774. PubMed ID: 27980321
[TBL] [Abstract][Full Text] [Related]
5. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
Tran D; Vallée M; Collette S; Senécal L; Lafrance JP; Dandavino R; Boucher A
Exp Clin Transplant; 2014 Aug; 12(4):323-7. PubMed ID: 24844288
[TBL] [Abstract][Full Text] [Related]
6. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
8. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients.
Uchida J; Iwai T; Kabei K; Machida Y; Kuwabara N; Naganuma T; Kumada N; Nakatani T
Transplant Proc; 2014; 46(2):532-6. PubMed ID: 24656005
[TBL] [Abstract][Full Text] [Related]
9. Conversion From Cyclosporine to Once-Daily Tacrolimus on 50:1 mg Basis: A Short-Term Pilot Study.
Shimada H; Uchida J; Kosoku A; Iwai T; Kabei K; Nishide S; Naganuma T; Kumada N; Takemoto Y; Nakatani T
Exp Clin Transplant; 2020 Feb; 18(1):1-7. PubMed ID: 31180299
[TBL] [Abstract][Full Text] [Related]
10. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
[TBL] [Abstract][Full Text] [Related]
11. Late conversion from tacrolimus to a belatacept-based immuno-suppression regime in kidney transplant recipients improves renal function, acid-base derangement and mineral-bone metabolism.
Schulte K; Vollmer C; Klasen V; Bräsen JH; Püchel J; Borzikowsky C; Kunzendorf U; Feldkamp T
J Nephrol; 2017 Aug; 30(4):607-615. PubMed ID: 28540602
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis for optimizing the modified release tacrolimus (Advagraf) after kidney transplantation: A prospective randomized trial.
Bakr MA; Nagib AM; Donia AF; Denewar AA; Abu-Elmagd MM; Abbas MH; Abdel-Rahman AM; Mashaly ME; Elsaftawy MM; Ghoneim MA
Saudi J Kidney Dis Transpl; 2018; 29(6):1267-1273. PubMed ID: 30588956
[TBL] [Abstract][Full Text] [Related]
13. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
Shuker N; Cadogan M; van Gelder T; Roodnat JI; Kho MM; Weimar W; Hesselink DA
Ther Drug Monit; 2015 Apr; 37(2):262-9. PubMed ID: 25265255
[TBL] [Abstract][Full Text] [Related]
14. Conversion From Steroid to Everolimus in Maintenance Kidney Transplant Recipients With Posttransplant Diabetes Mellitus.
Nanmoku K; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Yagisawa T
Exp Clin Transplant; 2019 Feb; 17(1):47-51. PubMed ID: 29911959
[TBL] [Abstract][Full Text] [Related]
15. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
16. Pilot Study Comparing the Efficacy, Safety, Convertibility, and Tacrolimus Trough Levels of Twice-Daily Tacrolimus (Prograf) to Once-Daily Tacrolimus (Advagraf) Among Standard-Risk Kidney Transplant Patients at the National Kidney and Transplant Institute.
Danguilan RA; Lamban A; Pamugas GEP
Transplant Proc; 2019 Oct; 51(8):2615-2619. PubMed ID: 31563241
[TBL] [Abstract][Full Text] [Related]
17. Conversion From Twice-Daily to Once-Daily Tacrolimus Among Egyptian Living-Donor Kidney Allograft Recipients: A Single-Center Experience.
Bakr MA; Nagib AM; Abbas MH; Donia AF
Exp Clin Transplant; 2019 Oct; 17(5):594-598. PubMed ID: 31050617
[TBL] [Abstract][Full Text] [Related]
18. A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single).
Yang SS; Choi JY; Cho WT; Park JB; Kim SJ
Transplant Proc; 2015 Apr; 47(3):617-21. PubMed ID: 25891697
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen.
Meçule A; Tinti F; Poli L; Bachetoni A; Umbro I; Nofroni I; Lai Q; Pretagostini R; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1024-7. PubMed ID: 21620042
[TBL] [Abstract][Full Text] [Related]
20. Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study.
Sańko-Resmer J; Boillot O; Wolf P; Thorburn D
Transpl Int; 2012 Mar; 25(3):283-93. PubMed ID: 22239105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
